Serial Addition and Task Switching Had Different THC Time Courses in Diabetic Neuropathy
A diabetic-neuropathy trial summarized in a medical-cannabis review found cognitive effects at different times depending on the task. One assessment time did not describe the entire cognitive response.
Early serial-addition differences were not persistent at every test
The review describes poorer paced serial-addition performance with the medium and high vaporized-THC conditions at fifteen minutes. Later comparisons at sixty, one hundred twenty and two hundred forty minutes did not show the same significant differences from placebo.
Task switching supplied a different observation
For Trail Making B, the high-THC condition differed from placebo at one hundred twenty minutes. A later finding on that task can coexist with a null serial-addition comparison at the same general stage of testing. The experiment did not identify one universal cognitive peak shared by every measure.
Report the function and assessment together
The evidence concerns selected human patients with painful diabetic neuropathy, not every cannabis user. It supports specifying which task changed and when, rather than declaring all cognition affected or recovered from one result. The comparison also does not establish an individual driving deadline or a blood-THC threshold. Both significant and null observations remain useful when the actual task, route and observation schedule accompany them.
Related analysis: the review’s broader findings and limitations.
Research cited
This analysis draws on the supplied review: Eadie and colleagues (2021). Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review. Frontiers in Psychiatry.
Study discussed in that review: DOI 10.1016/j.jpain.2015.03.008.
